14-1935776 · Philadelphia, PA
THE MISSION OF THE LUNG CANCER RESEARCH FOUNDATION IS TO IMPROVE LUNG CANCER OUTCOMES BY FUNDING RESEARCH FOR THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF LUNG CANCER.
Total revenue
$6.4M
FY2023
Total expenses
$6.4M
FY2023
Net assets
$3.6M
FY2023
Operating margin
-0.6%
NPLens analysis
FY18–FY2023 · from annual filings
Financial health
B
Derived analysis — not an official IRS designation.
Computed from FY2023 · derived analysis
FY2023 · program vs. administration vs. fundraising (Form 990, Part IX)
FY2023 · where revenue comes from (as reported)
Highest-paid officers, directors & key employees · FY2023.
ANTOINETTE WOZNIAK
CHIEF SCIENTIFIC OFFICER
$222,989
AUBREY RHODES
SENIOR VP, STRATEGY
$200,970
STACEY BOWERS
SR. DIRECTOR, COMMUNITY EN
$171,809
SHEILA SULLIVAN
SR. DIRECTOR, MARKETING & COMMUNICATION
$165,326
DENNIS CHILLEMI
EXECUTIVE DIRECTOR
$150,816
Each figure on this page traces to one of these source returns.
Health scores, efficiency ratios, peer percentiles, and outlier flags are derived analysis by NPLens — not official IRS designations. Figures are as reported on the organization's Form 990 filings. How these are computed →